The effect of intravenous recombinant human renin on blood pressure in pithed spontaneously hypertensive rats

  • Eur J Pharmacol. 1992 May 14;215(2-3):271-6. doi: 10.1016/0014-2999(92)90038-6.
M Shibasaki  1 ,  K Sudoh ,  M Asano ,  K Murakami
Affiliations
  • 1. Medicinal Research Laboratories II, Yamanouchi Pharmaceutical Co., Ltd., Ibaraki, Japan.
PMID: 1396991 DOI: 10.1016/0014-2999(92)90038-6
Abstract

The effect of highly purified Recombinant human Renin (rh-renin), expressed in Chinese hamster ovary cells, on mean blood pressure (MBP) was evaluated in pithed spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). Intravenous bolus injection of rh-renin produced dose-dependent increases in MBP in pithed SHR and WKY. The pressor response to rh-renin in pithed SHR was about 3 times as potent as that in pithed WKY. Intravenous infusion of rh-renin produced dose-dependent progressive increases in MBP during the first 40 min, reaching plateaus and thereafter MBP was maintained up to 120 min. This hypertensive response to rh-renin was antagonized by Renin inhibitors, YM-21095 and KRI-1314, which inhibited the reaction between rh-renin and tetradecapeptide competitively, with Ki values of 5.1 x 10(-10) and 4.3 x 10(-9) M, respectively. In rh-renin-infused pithed SHR, the hypotensive effect of YM-21095 was 37 times as potent as that of KRI-1314. These results suggest that rh-renin can stimulate the rat renin-angiotensin system, thereby producing Hypertension. Moreover, the rh-renin-infused rat model could be useful to evaluate the effect of Renin inhibitor.

Products